tykhr
sign in
free sign up
BioCryst Pharmaceuticals Inc
Biotechnology
Healthcare
BCRX
207 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
6.30
52 week high
9.39
high
7.04
52 week low
6.00
low
6.13
growth
4.80 %
previous Close
6.47
P/E ratio
market cap
1.61 B
div yield
0
usd
Sep 2024
qoq
revenue
117 M
7.09 %
net incoming
-14.03 M
-10.72 %
eps
0.00 %
-16.67 %
eps surprise
-16.67 %
net profit margin
-11.99 %
0.00 %
operating incoming
7.69 M
-12.20 %
net change in cash
18.86 M
418.24 %
cash on hand
96.84 M
20.74 %
cost of revenue
3.23 M
57.16 %
top